Dr. Capeding led the first Phase 3 trial ever completed for a dengue vaccine candidate. The results of this trial in Asia (involving Sanofi Pasteur’s dengue vaccine candidate) were published this summer, July 11, in The Lancet.
A paper co-authored by Sabin president Dr. Peter Hotez and published today inPLoS Neglected Tropical Diseases reports on the disease burden of neglected tropical diseases (NTDs) in India and South Asia. The press release below describes some of the significant findings from the study and also suggestions from the authors about how to control NTDs in the region.
Great news in the world of global health! A recent clinical trial for an experimental malaria vaccine has yielded successful results in protecting a large number of children against malaria with minimal side effects.